783 related articles for article (PubMed ID: 11884558)
1. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
2. Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization.
Hassett DE; Slifka MK; Zhang J; Whitton JL
J Virol; 2000 Sep; 74(18):8286-91. PubMed ID: 10954526
[TBL] [Abstract][Full Text] [Related]
3. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections.
Selin LK; Vergilis K; Welsh RM; Nahill SR
J Exp Med; 1996 Jun; 183(6):2489-99. PubMed ID: 8676069
[TBL] [Abstract][Full Text] [Related]
4. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
[TBL] [Abstract][Full Text] [Related]
5. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
6. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
Cornberg M; Sheridan BS; Saccoccio FM; Brehm MA; Selin LK
J Virol; 2007 Jan; 81(2):934-44. PubMed ID: 17079318
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
Selin LK; Nahill SR; Welsh RM
J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
[TBL] [Abstract][Full Text] [Related]
8. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
9. CD8(+)-T-cell response to secreted and nonsecreted antigens delivered by recombinant Listeria monocytogenes during secondary infection.
Tvinnereim AR; Hamilton SE; Harty JT
Infect Immun; 2002 Jan; 70(1):153-62. PubMed ID: 11748177
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
11. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
12. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
[TBL] [Abstract][Full Text] [Related]
13. High frequencies of virus-specific CD8+ T-cell precursors.
Seedhom MO; Jellison ER; Daniels KA; Welsh RM
J Virol; 2009 Dec; 83(24):12907-16. PubMed ID: 19812167
[TBL] [Abstract][Full Text] [Related]
14. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C
J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055
[TBL] [Abstract][Full Text] [Related]
15. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss.
Varga SM; Selin LK; Welsh RM
J Immunol; 2001 Feb; 166(3):1554-61. PubMed ID: 11160196
[TBL] [Abstract][Full Text] [Related]
16. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.
von Herrath MG; Yokoyama M; Dockter J; Oldstone MB; Whitton JL
J Virol; 1996 Feb; 70(2):1072-9. PubMed ID: 8551565
[TBL] [Abstract][Full Text] [Related]
17. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
[TBL] [Abstract][Full Text] [Related]
18. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
[TBL] [Abstract][Full Text] [Related]
19. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
20. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
